an "A" team if I have ever seen one Cellceuti

an "A" team if I have ever seen one

Cellceutix Corporate Bio Summary:

Chief Executive Officer and CFO : Leo Ehrlich, CPA : A founder of Cellceutix, he has served as Chief Financial Officer (CFO) and Director since inception in June 2007 and as CEO since November 2010. From 1999 to December 2007, Mr. Ehrlich had been a director at StatSure Diagnostic Systems, Inc. and has held different executive officer positions at that company including CEO, President and CFO . Mr. Ehrlich was also was a founder, CFO and director at Nanoviricides, Inc. from June 1, 2005. until May 2007. Mr. Ehrlich is a Certified Public Accountant and received his BBA from Bernard Baruch College of the City University of New York.

Chief Scientific Officer : Dr. Krishna Menon: Nearly 30 highly-relevant years in the drug development industry including being a recipient of the President’s Award during his time as a Research Associate at Eli Lilly for his instrumental role in choosing Alimta and Gemzar for development as cancer therapies. These blockbuster chemotherapies are still two of the most widely used drugs today and generated more than $3.3 billion in sales last year alone.

Scientific Advisory Board Member : Dr. Emil Frei: Widely regarded as one of the world’s leading oncologists with more than 40 years’ experience. His accomplishments include former Physician-in-Chief at the Dana-Farber Cancer Institute (where he still resides as Physician-in-Chief, Emeritus) and Chief of Medicine at the National Cancer Institute. If the name rings a bell, it’s because he was mentioned earlier for his role in the cure for childhood leukemia

Scientific Advisory Board Member : Dr. Samuel Danishefsky: Widely regarded as one of the world's leading chemists in cancer research, PhD in Chemistry from Harvard, recipient of the First Annual AACR-CICR Award for Outstanding Achievement in Chemistry in Cancer Research and Chairman of the Laboratory for Cancer Research Bioorganic Chemistry for Memorial Sloan-Kettering Cancer Center

Consultant Dr. Ashok Kumar : Dr. Kumar is a highly-regarded Molecular Biologist who received his Ph.D. from Jawaharlal Nehru University, one of the most prestigious schools in India, recipient of a Japan Society of Promotion of Sciences fellowship from the Government of Japan, extensively published in top scientific journals in the area of Immunology and Molecular Biology and until just recently, a faculty member in the Dept. of Immunology, Mayo Clinic, Rochester, MN

Advisor and Patent Attorney Dr. Paul Ginsberg : Dr. Ginsberg is the former Head of the New York Patent Department at Pfizer, Inc. where he represented Pfizer and their blockbuster drugs Viagra and Chantix on the intellectual property committees of the National Association of Manufacturers, the Chemical Manufacturers Association and the Biotechnology Industry Organization. He is perhaps most well-known as the author of the patent covering Schering-Plough's hugely successful product Claritin

When a company has this many big names in the industry standing behind its developments, it tends to swing open doors of opportunity to “Big Pharma” due to their connections and industry recognition